Eye Center of Second Hospital of Jilin University, Changchun, China.
Front Immunol. 2024 Jul 15;15:1406762. doi: 10.3389/fimmu.2024.1406762. eCollection 2024.
Immunopeptides have low toxicity, low immunogenicity and targeting, and broad application prospects in drug delivery and assembly, which are diverse in application strategies and drug combinations. Immunopeptides are particularly important for regulating ocular immune homeostasis, as the eye is an immune-privileged organ. Immunopeptides have advantages in adaptive immunity and innate immunity, treating eye immune-related diseases by regulating T cells, B cells, immune checkpoints, and cytokines. This article summarizes the application strategies of immunopeptides in innate immunity and adaptive immunity, including autoimmunity, infection, vaccine strategies, and tumors. Furthermore, it focuses on the mechanisms of immunopeptides in mediating ocular immunity (autoimmune diseases, inflammatory storms, and tumors). Moreover, it reviews immunopeptides' application strategies and the therapeutic potential of immunopeptides in the eye. We expect the immune peptide to get attention in treating eye diseases and to provide a direction for eye disease immune peptide research.
免疫肽具有低毒性、低免疫原性和靶向性,在药物输送和组装方面具有广阔的应用前景,其应用策略和药物组合多样。免疫肽在调节眼部免疫稳态方面尤为重要,因为眼睛是免疫特惠器官。免疫肽在适应性免疫和固有免疫方面具有优势,通过调节 T 细胞、B 细胞、免疫检查点和细胞因子来治疗与眼部免疫相关的疾病。本文总结了免疫肽在固有免疫和适应性免疫中的应用策略,包括自身免疫、感染、疫苗策略和肿瘤。此外,本文还重点关注了免疫肽在调节眼部免疫(自身免疫性疾病、炎症风暴和肿瘤)方面的作用机制。此外,还回顾了免疫肽在眼部的应用策略和免疫肽的治疗潜力。我们期望免疫肽在治疗眼部疾病方面得到重视,并为眼部疾病免疫肽研究提供方向。